Seer Inc. (SEER)
SEER trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.11
-1.86% on the day
Market cap
$116.8M
Micro cap
Revenue · 2025
$16.6M
+17.0% on 2024
Net income · 2025
-$73.6M
-444.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SEER on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001726445 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $16.6M |
| Net income | -$73.6M |
| Operating income | -$78.0M |
| Net margin | -444.0% |
| Operating margin | -470.5% |
| Revenue growth | +17.0% |
| Cash | $47.3M |
| Total assets | $296.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 7.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2021-01-29 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-18 |
| Latest proxy | DEFA14A | 2026-07-22 |
Source: SEC EDGAR submissions feed, 397 recent filings. All filings on EDGAR.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| QTRX | Quanterix Corporation | $3.15 | -0.32% | $149.0M |
| LAB | Standard BioTools Inc. | $0.6589 | +0.17% | $260.0M |
| NAUT | Nautilus Biotechnology Inc. | $2.05 | -5.53% | $260.9M |
| EYPT | EyePoint Inc. | $3.07 | -7.53% | $264.7M |
| RPID | Rapid Micro Biosystems Inc. | $0.8738 | -0.57% | $43.8M |
| CIRC | Circle8 Group Inc. | $0.3611 | -19.38% | $42.4M |
| PRPO | Precipio Inc. | $22.59 | 0.00% | $40.4M |
| HBIO | Harvard Bioscience Inc. | $8.27 | +0.36% | $37.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier